RTX A/S (CPH:RTX)

Sage Therapeutics Ratios and Metrics

Market cap in millions DKK. Fiscal year is October - September.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 8, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Market Capitalization	654	659	686	941	1,343	1,802
Market Cap Growth	-29.40%	-3.97%	-27.07%	-29.94%	-25.45%	29.60%
Enterprise Value	602	615	653	897	1,288	1,631
Last Close Price	82.00	82.60	83.60	115.00	165.00	213.29
PE Ratio	61.62	-	14.69	27.75	368.17	28.53
PS Ratio	1.15	1.27	0.86	1.39	2.79	3.08
PB Ratio	2.00	2.04	1.82	2.84	4.66	5.12
P/TBV Ratio	2.71	2.71	2.14	3.51	6.15	6.31
P/FCF Ratio	10.57	32.72	7.91	-	51.77	28.76
P/OCF Ratio	10.02	30.65	7.08	-	30.18	25.52
EV/Sales Ratio	1.06	1.19	0.82	1.32	2.67	2.79
EV/EBITDA Ratio	20.92	-	8.65	17.14	93.54	17.80
EV/EBIT Ratio	53.59	-	9.62	19.65	172.96	19.35
EV/FCF Ratio	9.73	30.56	7.53	-	49.65	26.04
Debt / Equity Ratio	0.17	0.17	0.15	0.18	0.21	0.15
Debt / EBITDA Ratio	1.96	-	0.68	0.99	3.01	0.53
Debt / FCF Ratio	0.91	2.74	0.65	-	2.37	0.83
Asset Turnover	1.18	0.97	1.40	1.30	0.95	1.17
Inventory Turnover	3.19	2.94	4.15	5.25	9.17	13.33
Quick Ratio	2.48	2.55	2.23	1.89	2.37	3.35
Current Ratio	3.29	3.45	2.98	2.59	2.67	3.52
Return on Equity (ROE)	3.29%	-8.76%	13.18%	10.94%	1.14%	18.05%
Return on Assets (ROA)	1.46%	-3.99%	7.48%	5.47%	0.91%	10.57%
Return on Capital (ROIC)	1.84%	-5.25%	10.29%	7.70%	1.23%	14.02%
Return on Capital Employed (ROCE)	2.80%	-	15.60%	11.30%	2.00%	20.00%
Earnings Yield	1.64%	-4.66%	6.81%	3.60%	0.27%	3.50%
FCF Yield	9.46%	3.06%	12.64%	-1.22%	1.93%	3.48%
Dividend Yield	-	-	-	-	-	1.17%
Payout Ratio	-	-	-	-	567.71%	33.19%
Buyback Yield / Dilution	2.32%	1.42%	-0.02%	1.25%	2.36%	1.51%
Total Shareholder Return	-	1.42%	-0.02%	1.25%	2.36%	2.68%

Updated Jan 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.